209 related articles for article (PubMed ID: 15561976)
1. Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.
Hohenstein B; Daniel C; Wagner A; Stasch JP; Hugo C
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F685-93. PubMed ID: 15561976
[TBL] [Abstract][Full Text] [Related]
2. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
[TBL] [Abstract][Full Text] [Related]
4. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
8. Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition.
Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2006 Jan; 290(1):F167-76. PubMed ID: 16048904
[TBL] [Abstract][Full Text] [Related]
9. Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis.
Cantaluppi V; Medica D; Mannari C; Stiaccini G; Figliolini F; Dellepiane S; Quercia AD; Migliori M; Panichi V; Giovannini L; Bruno S; Tetta C; Biancone L; Camussi G
Nephrol Dial Transplant; 2015 Mar; 30(3):410-22. PubMed ID: 25488895
[TBL] [Abstract][Full Text] [Related]
10. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats.
Chen YM; Hu-Tsai MI; Lin SL; Tsai TJ; Hsieh BS
Nephrol Dial Transplant; 2003 Dec; 18(12):2505-14. PubMed ID: 14605272
[TBL] [Abstract][Full Text] [Related]
11. Requirement of heat shock protein 90 in mesangial cell mitogenesis.
Pieper M; Rupprecht HD; Bruch KM; De Heer E; Schöcklmann HO
Kidney Int; 2000 Dec; 58(6):2377-89. PubMed ID: 11115071
[TBL] [Abstract][Full Text] [Related]
12. PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis.
Hohenstein B; Daniel C; Wittmann S; Hugo C
Nephrol Dial Transplant; 2008 Nov; 23(11):3427-36. PubMed ID: 18596129
[TBL] [Abstract][Full Text] [Related]
13. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo.
Daniel C; Wiede J; Krutzsch HC; Ribeiro SM; Roberts DD; Murphy-Ullrich JE; Hugo C
Kidney Int; 2004 Feb; 65(2):459-68. PubMed ID: 14717916
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
[TBL] [Abstract][Full Text] [Related]
16. Acute glomerular upregulation of ornithine decarboxylase is not essential for mesangial cell proliferation and matrix expansion in anti-Thy-1-nephritis.
Ketteler M; Westenfeld R; Gawlik A; de Heer E; Distler A
Nephrol Dial Transplant; 2000 Jan; 15(1):16-22. PubMed ID: 10607762
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis.
Stahl RA; Thaiss F; Disser M; Helmchen U; Hora K; Schlöndorff D
Kidney Int; 1993 Nov; 44(5):1036-47. PubMed ID: 8264133
[TBL] [Abstract][Full Text] [Related]
18. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.
Hartner A; Schöcklmann H; Pröls F; Müller U; Sterzel RB
Kidney Int; 1999 Oct; 56(4):1468-80. PubMed ID: 10504498
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo.
Haraguchi M; Okamura M; Konishi M; Konishi Y; Negoro N; Inoue T; Kanayama Y; Yoshikawa J
Kidney Int; 1997 Jun; 51(6):1838-46. PubMed ID: 9186873
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis.
Ziswiler R; Steinmann-Niggli K; Kappeler A; Daniel C; Marti HP
J Am Soc Nephrol; 1998 Nov; 9(11):2055-66. PubMed ID: 9808091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
